Monitor upcoming 10-Q or proxy filing for details on the award terms (vesting, performance conditions). This cluster reflects routine compensation, not sentiment — no immediate trading signal.
Price Chart
Executive Summary
Seven executives at Amylyx Pharmaceuticals, including both Co-CEOs, the CFO, CMO, and Chief Legal Officer, were awarded a total of approximately 1.8 million shares in a non-cash grant on March 5, 2026. These transactions are routine equity compensation awards and do not reflect open-market buying or selling activity.
Key Financial Metrics
Key Facts
- All 10 transactions were non-cash grants (Form 4 code 'A') of stock awards, totaling ~1.8 million shares.
- Executives involved include both Co-CEOs (Klee and Cohen), CFO (Frates), CMO (Bedrosian), and Chief Legal Officer (Mazzariello).
- No open-market purchases (P) or sales (S) were reported in the cluster.
- Total dollar value of transactions is $0 since no cash changed hands — these are standard equity compensation awards.
Financial Impact
$0 direct financial impact; ~1.8M shares granted, representing ~0.12% of market cap assuming $1.5B valuation and ~150M shares outstanding
Risk Factors
- Potential for modest future dilution as awarded shares vest.
- If awards are tied to aggressive performance targets, unmet goals could pressure management incentives.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (10 trades, 7d window) | cluster-AMLX-1773086427668 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 5, 2026 20d ago | 144 | $28.04 | awaiting T+20 | — | $26.93 (−3.96%) |
Sep 14, 2026 5w ago | Insider Cluster | $33.15 $26.85 | ▼ −19.00% | ▼ −21.73% | $26.93 (−18.76%) |
Sep 11, 2026 6w ago | 144 | $33.64 $27.48 | ▼ −18.31% | ▼ −20.57% | $26.93 (−19.95%) |
Aug 18, 2026 9w ago | 8-K | $35.11 $33.05 | ▼ −5.87% | ▼ −4.88% | $26.93 (−23.30%) |
Aug 15, 2026 10w ago | Institutional Cluster | $21.43 $33.15 | ▲ +54.69% | ▲ +56.67% | $26.93 (+25.66%) |
Aug 6, 2026 11w ago | 8-K | $24.19 $33.96 | ▲ +40.39% | ▲ +39.79% | $26.93 (+11.33%) |
Jun 11, 2026 19w ago | Institutional Cluster | $13.91 $18.38 | ▲ +32.14% | ▲ +30.24% | $26.93 (+93.60%) |
Apr 23, 2026 26w ago | DEFA14A | $17.32 $13.61 | ▼ −21.42% | ▼ −26.05% | $26.93 (+55.48%) |
Mar 2, 2026 34w ago | Insider Cluster | $15.30 $12.76 | ▼ −16.60% | ▼ −8.66% | $26.93 (+76.01%) |
Feb 23, 2026 35w ago | Insider Cluster | $13.90 $13.53 | ▲ +2.66% | ▼ −1.28% | $26.93 (−93.74%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers